ROSE PIERSON: Open Payments
NPI 1184739591 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,653 in 152 payments from 20 companies in 2025. Trend: 2023 $2,742 · 2024 $2,734 · 2025 $3,653
Food & beverage: $3,553Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 49 | $839 |
| AstraZeneca Pharmaceuticals LP | 16 | $769 |
| CSL Behring | 22 | $427 |
| GENZYME CORPORATION | 10 | $286 |
| Regeneron Healthcare Solutions, Inc. | 11 | $259 |
| LEO Pharma Inc. | 6 | $232 |
| Novartis Pharmaceuticals Corporation | 8 | $175 |
| Amgen Inc. | 9 | $169 |
| Verona Pharma, Inc. | 4 | $90 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, FASENRA, TEZSPIRE, Hizentra, ADBRY, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
